Pages that link to "Q35013893"

The following pages link to RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus (Q35013893):

Displaying 35 items.

• Transcriptional profiling of target of RNAIII-activating protein, a master regulator of staphylococcal virulence (Q24534681) (← links)
• Biologically inspired strategies for combating bacterial biofilms (Q27006003) (← links)
• Emerging concepts promising new horizons for marine biodiscovery and synthetic biology (Q28080553) (← links)
• Small molecule control of bacterial biofilms (Q28269575) (← links)
• Medicinal Chemistry as a Conduit for the Modulation of Quorum Sensing (Q30429785) (← links)
• Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants (Q33375040) (← links)
• Comparative genomics of Staphylococcus aureus musculoskeletal isolates. (Q33699183) (← links)
• Delayed wound healing in diabetic (db/db) mice with Pseudomonas aeruginosa biofilm challenge: a model for the study of chronic wounds (Q34129915) (← links)
• Quorum sensing and swarming migration in bacteria. (Q34353254) (← links)
• An association between milk and slime increases biofilm production by bovine Staphylococcus aureus (Q35030427) (← links)
• A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci (Q35124472) (← links)
• Innovative strategies for combating biofilm-based infections (Q35408141) (← links)
• Biofilm: the microbial "bunker" for intravascular catheter-related infection (Q35750323) (← links)
• Quorum sensing: a primer for food microbiologists (Q35777215) (← links)
• Treatment and prevention of enterococcal infections--alternative and experimental approaches (Q35873796) (← links)
• Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus (Q35947338) (← links)
• Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation (Q35947369) (← links)
• Staphylococcus aureus: the search for novel targets (Q36127840) (← links)
• Bench-to-bedside review: Quorum sensing and the role of cell-to-cell communication during invasive bacterial infection (Q37106083) (← links)
• Biofilms and their role in otorhinolaryngological disease (Q37135796) (← links)
• Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. (Q37543436) (← links)
• Microbial quorum sensing: a tool or a target for antimicrobial therapy? (Q37548534) (← links)
• Fighting bacterial infections—Future treatment options (Q37849011) (← links)
• Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal (Q37961556) (← links)
• Biomolecular mechanisms of staphylococcal biofilm formation. (Q38093647) (← links)
• Antibiofilm agents and implant-related infections in orthopaedics: where are we? (Q38107655) (← links)
• Siamycin attenuates fsr quorum sensing mediated by a gelatinase biosynthesis-activating pheromone in Enterococcus faecalis. (Q41941850) (← links)
• Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. (Q42747673) (← links)
• Biofilms 2003: emerging themes and challenges in studies of surface-associated microbial life (Q43116681) (← links)
• Quorum sensing in Staphylococci is regulated via phosphorylation of three conserved histidine residues (Q44730678) (← links)
• In vivo comparison of Dhvar-5 and gentamicin in an MRSA osteomyelitis prevention model (Q45146805) (← links)
• Synthesis of pyrrolidine-based hamamelitannin analogues as quorum sensing inhibitors in Staphylococcus aureus (Q59327167) (← links)
• Therapeutic frontiers: preventing and treating infectious diseases by inhibiting bacterial quorum sensing (Q80826620) (← links)
• Vaccine development for the prevention of staphylococcal mastitis in dairy cows (Q83983229) (← links)
• Current therapies in treatment and prevention of fracture wound biofilms: why a multifaceted approach is essential for resolving persistent infections (Q88672734) (← links)